BioSpace News Archive

GBS Inc. today announced that it will release its financial results for the second quarter ended December 31, 2021, shortly after the NASDAQ market close on Thursday, February 10.

Pneumoconiosis—a spectrum of lung disorders caused by inhalation of mineral dust particles—is unfortunately a common occupational hazard for people who work in mines and chemical industries.

Thermo Fisher Scientific Inc., the world leader in serving science, announced a multiyear partnership with Medidata Acorn AI, a Dassault Systèmes company leading the digital transformation of life sciences.

BioRestorative Provides Update on its Active Phase 2 Clinical Trial.

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today announced that Erik Harris has joined the Board of Directors.

Immagene and Selvita announce their cooperation on an integrated drug discovery project.

Miach Orthopaedics, Inc. announced Miach founder Dr. Martha Murray’s research on the development of the company’s BEAR® Implant was selected for the 2022 Orthopaedic Research and Education Foundation Clinical Research Award.

Rafarma Pharmaceuticals, Inc. is expanding its production capabilities as it is in active negotiations for the acquisition of two machines from BOBST, one of the world’s leading suppliers of substrate processing, printing and converting equipment and services for the label, flexible packaging, folding carton and corrugated board industries.

Tonix Pharmaceuticals Holding Corp. announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will participate virtually in the BIO CEO & Investor Conference, which is being held February 14-17, 2022.

Cyclacel Pharmaceuticals, Inc. today announced that the Company will participate in the 2022 BIO CEO & Investor Conference on February 14-17, 2022.